S100A2 downregulation is significantly associated with poor differentiation, tumor invasion, and lymph node metastasis in vivo [93,94,95], and unfavorable survival in patients with gastric cancer in vivo [93,94]. The gene discussed is S100A2; the disease is metastatic malignant neoplasm in the lymph nodes.